Verition Fund Management
PLX icon

Verition Fund Management’s Protalix BioTherapeutics PLX Stock Holding History

Verition Fund Management’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,465
Closed -$29.6K – 2518
2024
Q1 		$29.6K Buy
+23,465
New +$29.6K ﹤0.01% 2050
2023
Q3 		– Sell
-54,474
Closed -$109K – 2202
2023
Q2 		$109K Buy
+54,474
New +$109K ﹤0.01% 1684